Evans et al. observed that GLP-1 RAs reduced cardiovascular mortality by 13% (HR: 0.87; 95% CI: 0.78-0.96) and nonfatal myocardial infarction (MI) by 9% (HR: 0.91; 95% CI: 0.81-1.01). This evidence concerns the gene GLP1R and myocardial infarction.